Paratek Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:PRTK)

$4.45
+0.05 (+1.14 %)
(As of 09/20/2019 04:00 PM ET)
Today's Range
$4.33
Now: $4.45
$4.53
50-Day Range
$2.96
MA: $4.13
$5.76
52-Week Range
$2.87
Now: $4.45
$12.20
Volume507,400 shs
Average Volume344,316 shs
Market Capitalization$144.78 million
P/E RatioN/A
Dividend YieldN/A
Beta1.74

Analyst Ratings

Paratek Pharmaceuticals (NASDAQ:PRTK) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Paratek Pharmaceuticals in the last 12 months. Their average twelve-month price target is $21.60, suggesting that the stock has a possible upside of 385.39%. The high price target for PRTK is $27.00 and the low price target for PRTK is $12.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.002.832.862.86
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.60$19.3333$23.7143$24.8571
Price Target Upside: 385.39% upside414.18% upside364.08% upside299.47% upside

Paratek Pharmaceuticals (NASDAQ:PRTK) Consensus Price Target History

Paratek Pharmaceuticals (NASDAQ:PRTK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/9/2019HC WainwrightSet Price TargetBuy$27.00High
5/9/2019WedbushReiterated RatingOutperform$17.00 ➝ $12.00High
5/9/2019LADENBURG THALM/SH SHReiterated RatingBuyHigh
3/18/2019Canaccord GenuitySet Price TargetBuy$25.00Low
10/3/2018GuggenheimSet Price TargetBuy$26.00High
8/27/2018Bank of AmericaInitiated CoverageNeutral ➝ Neutral$13.00High
8/2/2018Cantor FitzgeraldReiterated RatingBuy$50.00Low
3/4/2018Leerink SwannReiterated RatingOutperformLow
3/2/2018Raymond JamesReiterated RatingStrong-Buy ➝ Outperform$36.00High
3/2/2018UBS GroupDowngradeStrong-Buy ➝ OutperformHigh
10/24/2017Robert W. BairdReiterated RatingBuy$40.00N/A
(Data available from 9/21/2017 forward)
This page was last updated on 9/21/2019 by MarketBeat.com Staff

Featured Article: Call Option

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel